IMAX (IMAX) Projected to Post Quarterly Earnings on Wednesday

IMAX (NYSE:IMAX) is projected to post its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect IMAX to post earnings of $0.43 per share and revenue of $120.2970 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 4:30 PM ET.

IMAX Stock Up 5.2%

IMAX opened at $37.95 on Wednesday. The stock has a market cap of $2.04 billion, a P/E ratio of 53.45, a P/E/G ratio of 1.78 and a beta of 0.38. IMAX has a 12 month low of $20.48 and a 12 month high of $39.98. The company has a fifty day simple moving average of $36.34 and a 200 day simple moving average of $33.35.

Institutional Investors Weigh In On IMAX

Institutional investors and hedge funds have recently made changes to their positions in the stock. CIBC Private Wealth Group LLC bought a new position in shares of IMAX in the third quarter valued at $27,000. Quarry LP grew its holdings in IMAX by 166.8% during the fourth quarter. Quarry LP now owns 875 shares of the company’s stock worth $32,000 after purchasing an additional 547 shares during the period. Caitong International Asset Management Co. Ltd increased its position in IMAX by 2,310.4% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock worth $38,000 after buying an additional 1,109 shares during the last quarter. Aster Capital Management DIFC Ltd raised its stake in IMAX by 863.0% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock valued at $62,000 after buying an additional 1,493 shares during the period. Finally, Kestra Advisory Services LLC bought a new stake in IMAX in the 4th quarter valued at $74,000. Institutional investors own 93.51% of the company’s stock.

Analyst Upgrades and Downgrades

IMAX has been the subject of several recent analyst reports. JPMorgan Chase & Co. upgraded IMAX from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $32.00 to $47.00 in a report on Monday, December 15th. Roth Mkm reaffirmed a “buy” rating and issued a $42.00 price target on shares of IMAX in a research note on Monday, December 8th. Wall Street Zen raised shares of IMAX from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 7th. Barrington Research reissued an “outperform” rating and issued a $42.00 price target on shares of IMAX in a research note on Monday, January 26th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of IMAX in a research report on Monday, December 29th. Ten investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, IMAX has an average rating of “Moderate Buy” and a consensus price target of $42.70.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.